BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• 

  Biotech Beach

  June 1st Research Roundup

  There are plenty of great scientific research stories out this week from a tool to delete gene products to the growth of whole muscles incorporated into a biohybrid robot. Here’s a look at just a few of them.

  May 31, 2018

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  FDA Chains Clinical Hold on CRISPR/ Vertex Sickle Cell Disease IND

  Shares of CRISPR Therapeutics plunged dramatically Wednesday after the U.S. Food and Drug Administration placed a clinical hold on a planned sickle cell disease treatment the company was in the process of developing with Vertex Pharmaceuticals.

  May 31, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Alzheimer’s Company Cortexyme Closes $76 Million Series B Financing Round with Pfizer, Takeda and Google Participating

  South San Francisco-based Cortexyme closed on a $76 million Series B financing round.

  May 31, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Nektar Therapeutics’ Big Week: Syndax Cancer Collaboration and New Opioid Submission

  It’s been a busy week for Nektar Therapeutics with the announcement of an NDA submission to the FDA for NKTR-181 and a non-exclusive, clinical collaboration deal with Syndax Pharmaceuticals.

  May 31, 2018

   · 

  2 min read

   · 

  Mark Terry
• Drug Development

  ABIVAX Presents New Data on ABX464 Mechanism of Action at 16th European Meeting on HIV & Hepatitis

  ABIVAX (Euronext Paris: FR0012333284 - ABVX), today unveiled new data characterizing the mechanism of action of its lead Phase 2 clinical candidate ABX464.

  May 31, 2018

   · 

  4 min read
• Business

  MYM Announces Hiring of Master Grower for Weedon Project

  MYM Nutraceuticals Inc. is pleased to announce the hiring of Joel Lalancette as Master Grower.

  May 31, 2018

   · 

  4 min read
• Intec Pharma to Present at Jefferies 2018 Healthcare Conference

  Intec Pharma Ltd. (NASDAQ: NETC) (TASE: NTEC) (“Intec” or “the Company”) today announces that Company management will participate at the upcoming Jefferies 2018 Healthcare Conference taking place June 5 - 8, 2018 in New York City.

  May 31, 2018

   · 

  3 min read
• Drug Development

  MEI Pharma and Helsinn Group Announce Successful Interim Analysis of Pracinostat/Azacitidine Phase 2 Combination Study in Higher Risk Myelodysplastic Syndrome (MDS) Patients

  Predefined Patient Retention Threshold Met: 10% Early Discontinuation Rate Due to Adverse Events Supports Expansion of Patient Enrollment

  May 31, 2018

   · 

  9 min read
• New Survey Highlights Lack of Awareness of Neurologic Effects Related to Excessive Sleepiness in Patients with Obstructive Sleep Apnea

  Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced findings from a new survey of the opinions of specialist physicians who treat patients with obstructive sleep apnea (OSA).

  May 31, 2018

   · 

  8 min read
• Business

  Buffalo, NY Travel Nurse Agency Celebrates Anniversary with Hiring Push

  GHR Travel Nursing, a travel nursing agency based in Buffalo, New York, is celebrating the completion of their first year of operations in June.

  May 31, 2018

   · 

  2 min read